Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1545) 1545
Paper (701) 701
Publication (507) 507
Newspaper Article (483) 483
Report (195) 195
Book / eBook (52) 52
Patent (8) 8
Data Set (6) 6
Dissertation (4) 4
Conference Proceeding (3) 3
Magazine Article (3) 3
Book Chapter (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
experiment (764) 764
physics (726) 726
cern lhc coll (717) 717
experimental results (710) 710
high energy physics - experiment (690) 690
particle physics (680) 680
physics - high energy physics - experiment (598) 598
cms (549) 549
p p: scattering (548) 548
high energy physics (538) 538
p p: colliding beams (490) 490
physics of elementary particles and fields (376) 376
13000 gev-cms (366) 366
phenomenology (349) 349
particle physics - experiment (279) 279
scattering [p p] (250) 250
nuclear experiment (240) 240
hep (227) 227
8000 gev-cms (212) 212
colliding beams [p p] (212) 212
hadron-hadron scattering (206) 206
background (202) 202
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (168) 168
ex (166) 166
supersymmetry (117) 117
physics, particles & fields (116) 116
transverse momentum: missing-energy (114) 114
channel cross section: upper limit (107) 107
[ phys.hexp ] physics [physics]/high energy physics - experiment [hep-ex] (106) 106
cern lab (106) 106
astrophysics (101) 101
mass dependence (96) 96
final state:jet lepton (95) 95
elementary particles, quantum field theory (93) 93
quantum field theories, string theory (93) 93
index medicus (90) 90
transverse momentum dependence (87) 87
animals (85) 85
high energy astrophysical phenomena (81) 81
classical and quantum gravitation, relativity theory (80) 80
quantum physics (80) 80
data analysis method (79) 79
top: pair production (78) 78
kinematics (77) 77
bottom: particle identification (76) 76
nuclear physics (76) 76
jet: bottom (75) 75
rapidity dependence (75) 75
astronomy & astrophysics (71) 71
z0: leptonic decay (71) 71
channel cross section: branching ratio: upper limit (68) 68
muon: pair production (67) 67
higgs particle: hadroproduction (66) 66
114 physical sciences (63) 63
quantum chromodynamics: perturbation theory (63) 63
final state:jet dilepton (62) 62
genetics & heredity (61) 61
channel cross section: measured (59) 59
instrumentation and detectors (59) 59
nuclear and high energy physics (57) 57
jet: transverse momentum (55) 55
mass spectrum: (55) 55
differential cross section: measured (52) 52
transverse momentum (52) 52
electroweak interaction (50) 50
lead (50) 50
bottom: pair production (49) 49
new physics: search for (49) 49
physics and astronomy (47) 47
squark: pair production (47) 47
w: leptonic decay (47) 47
analysis (46) 46
beyond standard model (46) 46
female (46) 46
mass: lower limit (46) 46
physics, nuclear (46) 46
upper limit [channel cross section] (45) 45
collisions (44) 44
jet lepton (44) 44
jet: multiplicity (44) 44
male (44) 44
sensitivity (44) 44
final state:jet (43) 43
7000 gev-cms (42) 42
humans (42) 42
numerical calculations: monte carlo (42) 42
missing-energy [transverse momentum] (41) 41
research (41) 41
gravitation (40) 40
higgs particle: hadronic decay (40) 40
higher-order: 1 (40) 40
inbreeding (40) 40
narrow resonance (40) 40
rapidity (40) 40
signature (40) 40
z0: associated production (40) 40
structure (38) 38
tau: pair production (38) 38
large hadron collider (37) 37
dijet (36) 36
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. La casa natal de José Martí
: breve historia del inmueble y del museo
by Caballero, Armando O
2003, ISBN 9789597126126, 61 p., [4] p. of plates
Martí, José, 1853-1895 Homes and haunts | Havana (Cuba) Buildings, structures, etc
Book
Details down arrow
2. La mujer en el 95
by Caballero, Armando O
1983, 127
Women | Partido Revolucionario Cubano | Cuba History | History
Book
Details down arrow
3. Full Text Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial
by Salles, Gilles, Prof and Seymour, John Francis, Prof and Offner, Fritz, Prof and López-Guillermo, Armando, MD and Belada, David, MD and Xerri, Luc, Prof and Feugier, Pierre, Prof and Bouabdallah, Réda, MD and Catalano, John Vincent, FRACP and Brice, Pauline, MD and Caballero, Dolores, MD and Haioun, Corinne, Prof and Pedersen, Lars Moller, MD and Delmer, Alain, Prof and Simpson, David, FRACP and Leppa, Sirpa, MD and Soubeyran, Pierre, Prof and Hagenbeek, Anton, Prof and Casasnovas, Olivier, MD and Intragumtornchai, Tanin, Prof and Fermé, Christophe, MD and da Silva, Maria Gomes, MD and Sebban, Catherine, MD and Lister, Andrew, Prof and Estell, Jane A, FRACP and Milone, Gustavo, MD and Sonet, Anne, MD and Mendila, Myriam, MD and Coiffier, Bertrand, Prof and Tilly, Hervé, Prof
Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9759, pp. 42 - 51
Summary Background Patients with follicular lymphoma can have long survival times, but disease progression typically occurs 3–5 years after initial treatment.... 
Internal Medicine | SINGLE-AGENT | MEDICINE, GENERAL & INTERNAL | PREDNISONE | THERAPY | FREE SURVIVAL | CYCLOPHOSPHAMIDE | VINCRISTINE | NON-HODGKINS-LYMPHOMA | TERM-FOLLOW-UP | INDOLENT | CELL | Lymphoma, Follicular - drug therapy | Humans | Middle Aged | Rituximab | Male | Antineoplastic Agents - therapeutic use | Tumor Burden | Remission Induction | Disease Progression | Young Adult | Aged, 80 and over | Adult | Female | Aged | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Immunologic Factors - therapeutic use | Chemotherapy | Lymphomas | Drug therapy | Health aspects | Cancer | Studies | Stock options | Educational materials | Cancer therapies | Cervical cancer | Tropical diseases | Skin cancer | Side effects | infection | lymphoma | survival | clinical trials | Maintenance | intervention | chemotherapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Changes in butterfly distributions and species assemblages on a Neotropical mountain range in response to global warming and anthropogenic land use
by Arcángel Molina-Martínez and Jorge L. León-Cortés and Helen M. Regan and Owen T. Lewis and Darío Navarrete and Ubaldo Caballero and Armando Luis-Martínez
Diversity and Distributions, ISSN 1366-9516, 12/2016, Volume 22, Issue 11/12, pp. 1085 - 1098
Aim: To assess the changes in the elevational distribution of 151 butterfly species over a period of 22 years (1988-2011) and investigate whether these changes... 
BIODIVERSITY RESEARCH | tropical montane ecosystem | mountain biodiversity | butterfly assemblages | elevational gradient | Oaxaca | climate change | RAREFACTION | CLIMATE-CHANGE | TROPICAL MOUNTAIN | EXTRAPOLATION | UPSLOPE SHIFTS | CONSERVATION | ECOLOGY | DIVERSITY | HIGHLANDS | BIODIVERSITY CONSERVATION | LEPIDOPTERA | PRELIMINARY APPRAISAL | Ecosystems | Mountain ecology | Protection and preservation | Environmental aspects | Air pollution | Global warming | Butterflies | Land use | Biological diversity | Biogeography | Butterflies & moths
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Inferring the Nature of Missing Heritability in Human Traits Using Data from the GWAS Catalog
by Lopez-Cortegano, E and Caballero, A
GENETICS, ISSN 0016-6731, 07/2019, Volume 212, Issue 3, pp. 891 - 904
Thousands of genes responsible for many diseases and other common traits in humans have been detected by Genome Wide Association Studies (GWAS) in the last... 
COMMON VARIANTS | FITNESS | GWAS | METAANALYSIS | RARE | GENETIC ARCHITECTURE | prediction of complex traits | PSORIASIS SUSCEPTIBILITY LOCI | INCREASE | GENETICS & HEREDITY | missing heritability | big data | SELECTION | COMPLEX TRAITS | GENOME-WIDE ASSOCIATION | Genetic effects | Body mass index | Computer simulation | Cardiovascular disease | Genomes | Heritability | Mathematical models | Diabetes | Estimates | Loci
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Lenalidomide in combination with R‐ESHAP in patients with relapsed or refractory diffuse large B‐cell lymphoma: a phase 1b study from GELTAMO group
by Martín, Alejandro and Redondo, Alba M and Dlouhy, Iván and Salar, Antonio and González‐Barca, Eva and Canales, Miguel and Montes‐Moreno, Santiago and Ocio, Enrique M and López‐Guillermo, Armando and Caballero, Dolores and Grp Espanol de Linfomas and Spanish Group for Lymphomas and Autologous Bone Marrow (GELTAMO) and the Grupo Español de Linfomas y Trasplante Autólogo de Médula Ósea (GELTAMO)
British Journal of Haematology, ISSN 0007-1048, 04/2016, Volume 173, Issue 2, pp. 245 - 252
Summary Diffuse large B‐cell lymphoma (DLBCL) patients failing rituximab‐containing therapy have a poor outcome with the current salvage regimens. We conducted... 
R‐ESHAP | lenalidomide | diffuse large B‐cell lymphoma | salvage | rituximab | Rituximab | R-ESHAP | Salvage | Lenalidomide | Diffuse large B-cell lymphoma | MULTIPLE-MYELOMA | OPEN-LABEL | diffuse large B-cell lymphoma | BORTEZOMIB | CHEMOTHERAPY | TRANSPLANTATION | IN-VITRO | PLUS DEXAMETHASONE | CHOP | HEMATOLOGY | ELDERLY-PATIENTS | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Neoplasm Recurrence, Local - drug therapy | Male | Cytarabine - adverse effects | Cisplatin - administration & dosage | Dose-Response Relationship, Drug | Young Adult | Thalidomide - analogs & derivatives | Adult | Female | Remission Induction - methods | Thalidomide - adverse effects | Prednisone - administration & dosage | Etoposide - adverse effects | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Etoposide - administration & dosage | Treatment Outcome | Thalidomide - administration & dosage | Cytarabine - administration & dosage | Maximum Tolerated Dose | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Cisplatin - adverse effects | Aged | Chronic Disease | Salvage Therapy - methods | Care and treatment | Relapse | Lymphomas | Angiogenesis inhibitors | Diseases | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group
by Alonso‐Álvarez, Sara and Magnano, Laura and Alcoceba, Miguel and Andrade‐Campos, Marcio and Espinosa‐Lara, Natalia and Rodríguez, Guillermo and Mercadal, Santiago and Carro, Itziar and Sancho, Juan M and Moreno, Miriam and Salar, Antonio and García‐Pallarols, Francesc and Arranz, Reyes and Cannata, Jimena and Terol, María José and Teruel, Ana I and Rodríguez, Antonia and Jiménez‐Ubieto, Ana and González de Villambrosia, Sonia and Bello, José L and López, Lourdes and Monsalvo, Silvia and Novelli, Silvana and Cabo, Erik and Infante, María S and Pardal, Emilia and García‐Álvarez, María and Delgado, Julio and González, Marcos and Martín, Alejandro and López‐Guillermo, Armando and Caballero, María D
British Journal of Haematology, ISSN 0007-1048, 09/2017, Volume 178, Issue 5, pp. 699 - 708
Summary The diagnostic criteria for follicular lymphoma (FL) transformation vary among the largest series, which commonly exclude histologically‐documented... 
follicular lymphoma | transformation | cumulative incidence | IMMUNOCHEMOTHERAPY | RESPONSE CRITERIA | INDOLENT | TRANSPLANTATION | TRIAL | MAINTENANCE | B-CELL LYMPHOMA | INTERNATIONAL PROGNOSTIC INDEX | NON-HODGKINS-LYMPHOMA | OUTCOMES | HEMATOLOGY | Risk Assessment - methods | Lymphoma, Follicular - drug therapy | Prognosis | Lymphoma, Follicular - pathology | Humans | Middle Aged | Lymphoma, Follicular - mortality | Male | Antineoplastic Agents - therapeutic use | Disease Progression | Young Adult | Rituximab - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Spain - epidemiology | Adolescent | Survival Analysis | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Cell Transformation, Neoplastic - drug effects | Cell Transformation, Neoplastic - pathology | Neoplasm Staging | Antimitotic agents | Lymphomas | Transplantation | Antineoplastic agents | Risk factors | Stem cells | Medical research | Therapy | Autografts | Transformation | Risk groups | Clinical trials | Stem cell transplantation | Rituximab | Males | Risk analysis | Survival | Patients | Lymphoma | Incidence | Confidence intervals | Transformations | Diagnostic systems | Females
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group
by Redondo, Alba M and Valcárcel, David and González‐Rodríguez, Ana P and Suárez‐Lledó, María and Bello, José L and Canales, Miguel and Gayoso, Jorge and Colorado, Mercedes and Jarque, Isidro and Campo, Raquel and Arranz, Reyes and Terol, María J and Rifón, José J and Rodríguez, María J and Ramírez, María J and Castro, Nerea and Sánchez, Andrés and López‐Jiménez, Javier and Montes‐Moreno, Santiago and Briones, Javier and López, Aurelio and Palomera, Luis and López‐Guillermo, Armando and Caballero, Dolores and Martín, Alejandro and GEL-TAMO and Grupo Español de Linfomas y Trasplante Autólogo de Médula Ósea (GELTAMO) and the Grupo Español de Linfomas y Trasplante Autólogo de Médula Ósea (GELTAMO)
British Journal of Haematology, ISSN 0007-1048, 03/2019, Volume 184, Issue 5, pp. 797 - 807
Summary We conducted a phase 2 trial to evaluate the safety and efficacy of bendamustine instead of BCNU (carmustine) in the BEAM (BCNU, etoposide, cytarabine... 
BEAM | clinical trial | aggressive lymphomas | autologous stem‐cell transplantation | bendamustine | autologous stem-cell transplantation | FDG-PET | AUTO-SCT | BEAM CHEMOTHERAPY | II TRIAL | PROGNOSTIC VALUE | ETOPOSIDE | POSITRON-EMISSION-TOMOGRAPHY | NON-HODGKIN-LYMPHOMA | HIGH-DOSE CHEMOTHERAPY | Y-90 IBRITUMOMAB TIUXETAN | HEMATOLOGY | Antimitotic agents | Medical research | Care and treatment | Analysis | Stem cells | Clinical trials | Medicine, Experimental | Lymphomas | Transplantation | Antineoplastic agents | Autografts | Transplants & implants | Feasibility studies | Stem cell transplantation | Etoposide | Multivariate analysis | Metabolism | Lymphoma | Patients | Survival | Confidence intervals | Cytarabine | Melphalan | Remission | Conditioning
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population
by Magnano, Laura and Alonso‐Alvarez, Sara and Alcoceba, Miguel and Rivas‐Delgado, Alfredo and Muntañola, Anna and Nadeu, Ferran and Setoain, Xavier and Rodríguez, Sonia and Andrade‐Campos, Marcio and Espinosa‐Lara, Natalia and Rodríguez, Guillermo and Sancho, Juan Manuel and Moreno, Miriam and Mercadal, Santiago and Carro, Itziar and Salar, Antonio and Garcia‐Pallarols, Francesc and Arranz, Reyes and Cannata, Jimena and Terol, María J and Teruel, Ana I and Jiménez‐Ubieto, Ana and Rodriguez, Antonia and González de Villambrosía, Sonia and Bello, José L and López, Lourdes and Novelli, Silvana and Cabo, Erik and Infante, María E and Pardal, Emilia and Monsalvo, Silvia and González, Marcos and Martín, Alejandro and Caballero, M. Dolores and López‐Guillermo, Armando and GELTAMO and Grupo Español de Linfomas y Trasplante Autólogo de Médula Ósea (GELTAMO) and the Grupo Español de Linfomas y Trasplante Autólogo de Médula Ósea (GELTAMO)
British Journal of Haematology, ISSN 0007-1048, 05/2019, Volume 185, Issue 3, pp. 480 - 491
Summary The use of immunochemotherapy has improved the outcome of follicular lymphoma (FL). Recently, complete response at 30 months (CR30) has been suggested... 
follicular lymphoma | complete response | survival | 1ST-LINE TREATMENT | SURROGATE END-POINT | FREE SURVIVAL | R-CHOP | PLUS RITUXIMAB | INITIAL TREATMENT | PROGNOSTIC VALUE | TRIAL | THERAPY | CVP | HEMATOLOGY | Lymphomas | Life expectancy | Health aspects | Analysis | Training | Life span | Sex | Rituximab | Multivariate analysis | Lymphoma | Patients | Survival
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Accelerated inbreeding depression suggests synergistic epistasis for deleterious mutations in Drosophila melanogaster
by Domínguez-García, Sara and García, Carlos and Quesada, Humberto and Caballero, Armando
Heredity, ISSN 0018-067X, 09/2019, Volume 123, Issue 6, pp. 709 - 722
Epistasis may have important consequences for a number of issues in quantitative genetics and evolutionary biology. In particular, synergistic epistasis for... 
Inbreeding depression | Recombination | Populations | Computer simulation | Drosophila | Natural populations | Biological evolution | Epistasis | Population genetics | Natural selection | Quantitative genetics | Insects | Alleles | Genetics | Inbreeding | Mathematical models | Mutation | Fitness | Evolutionary genetics | Quantitative trait
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text The nature of genetic variation for complex traits revealed by GWAS and regional heritability mapping analyses
by Caballero, Armando and Tenesa, Albert and Keightley, Peter D
Genetics, ISSN 0016-6731, 2015, Volume 201, Issue 4, pp. 1601 - 1613
We use computer simulations to investigate the amount of genetic variation for complex traits that can be revealed by single-SNP genome-wide association... 
Quantitative trait variation | Missing heritability | Additive genetic variance | Complex traits | Fitness | quantitative trait variation | RARE | VARIANTS | additive genetic variance | complex traits | HUMAN HEIGHT | EVOLUTION | fitness | DISEASE | GENETICS & HEREDITY | ARCHITECTURE | missing heritability | SELECTION | ASSOCIATION | Genetic Variation | Genome-Wide Association Study | Animals | Quantitative Trait, Heritable | Computer Simulation | Humans | Genetic Pleiotropy | Mice | Models, Genetic | Polymorphism, Single Nucleotide | Quantitative trait loci | Genome-wide association studies | Usage | Single nucleotide polymorphisms | Genetic variation | Analysis | Genotype & phenotype | Genomes | Biological variation | Genomics | Investigations
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Allelic diversity and its implications for the rate of adaptation
by Caballero, Armando and García-Dorado, Aurora
Genetics, ISSN 0016-6731, 12/2013, Volume 195, Issue 4, pp. 1373 - 1384
Genetic variation is usually estimated empirically from statistics based on population gene frequencies, but alternative statistics based on allelic diversity... 
FINITE ISLAND MODEL | selection limits | SAMPLING THEORY | GENETIC DIFFERENTIATION | F-ST | diffusion approximations | number of alleles | SEGREGATING SITES | response to selection | heterozygosity | SUBDIVIDED POPULATION | ARTIFICIAL SELECTION | RARE ALLELES | GENETICS & HEREDITY | gene diversity | G(ST) | SELECTIVELY NEUTRAL ALLELES | Time Factors | Adaptation, Physiological - genetics | Gene Frequency | Selection, Genetic | Models, Genetic | Mutation | Evolution, Molecular | Allelomorphism | Heterozygosis | Analysis | Research | Adaptation (Biology) | Biological diversity | Heterozygosity | Genetics | Genetic diversity | Genes | Adaptation | Investigations
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text An Amphotericin B derivative equally potent to Amphotericin B and with increased safety
by Antillón, Armando and De Vries, Alexander H and Espinosa-Caballero, Marcel and Falcón-González, José Marcos and Flores Romero, David and González-Damián, Javier and Jiménez-Montejo, Fabiola Eloísa and León-Buitimea, Angel and López-Ortiz, Manuel and Magaña, Ricardo and Marrink, Siewert J and Morales-Nava, Rosmarbel and Periole, Xavier and Reyes-Esparza, Jorge and Rodríguez Lozada, Josué and Santiago-Angelino, Tania Minerva and Vargas González, María Cristina and Regla, Ignacio and Carrillo-Tripp, Mauricio and Fernández-Zertuche, Mario and Rodríguez-Fragoso, Lourdes and Ortega-Blake, Iván
PLoS ONE, ISSN 1932-6203, 09/2016, Volume 11, Issue 9, p. e0162171
Amphotericin B is the most potent antimycotic known to date. However due to its large collateral toxicity, its use, although long standing, had been limited.... 
CONTAINING MEMBRANES | SELF-ASSOCIATION | FREE-ENERGY CALCULATIONS | LECITHIN LIPOSOMES | MODEL MEMBRANES | OXIDATIVE DAMAGE | MULTIDISCIPLINARY SCIENCES | ION-CHANNEL | FORCE-FIELD | MOLECULAR-DYNAMICS SIMULATIONS | HISTOGRAM ANALYSIS METHOD | Molecular dynamics | Antiparasitic agents | Amphotericin B | Chemical synthesis | Biotechnology | Arid zones | Toxicity | Electrophysiology | Lipids | Pharmacology | Selectivity | Derivatives | Toxicology | Histidine | Sterols | Antibiotics | Safety | Dimerization | Pore formation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights